Indeed, the data obtained showed that individuals carrying variant GSTO1*AA (rs4925) and variant GSTO2*GG (rs156697) genotypes exhibit higher odds of COVID-19 development, contrary to ones carrying referent alleles. This evidence concerns the gene GSTO1 and COVID-19.